/Companies

Checkpoint Therapeutics

Waltham, US · Founded 2014 · Delaware corporation

Find your way into Checkpoint Therapeutics

Sign up to see every warm intro you have to Checkpoint Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Checkpoint Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JF
James F. Oliviero, IIIExecutive
GGGarrett Gray
Garrett GrayExecutive
DJ
David J. HorinExecutive

Board

MW
Michael WeissBoard director
LA
Lindsay A. RosenwaldBoard director
BS
Barry SalzmanBoard director
AS
Amit SharmaBoard director
NH
Neil HerskowitzBoard director
CB
Christian BechonBoard director
SB
Scott BoilenBoard director

Reported raises · per SEC filings

Form D private placements

$57.8M disclosed across 1 of 5 rounds · 2015–2024

▶Undisclosed amountofferedJul 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry SalzmanDirector
  • Michael WeissDirector
  • Amit SharmaDirector
  • Neil HerskowitzDirector
  • Christian BechonDirector
  • Lindsay A. RosenwaldDirector
  • James F. Oliviero, IIIExecutive Officer, Director
  • Garrett GrayExecutive Officer
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Garrett GrayExecutive Officer
  • James F. Oliviero, IIIExecutive Officer, Director
  • Michael WeissDirector
  • Christian BechonDirector
  • Lindsay A. RosenwaldDirector
  • Barry SalzmanDirector
  • Neil HerskowitzDirector
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedApr 2023 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christian BechonDirector
  • Lindsay A. RosenwaldDirector
  • Garrett GrayExecutive Officer
  • Neil HerskowitzDirector
  • Michael WeissDirector
  • Barry SalzmanDirector
  • James F. Oliviero, IIIExecutive Officer, Director
  • Scott BoilenDirector
Placement agents
H.C. Wainwright & Co., LLC
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedMar 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James F. Oliviero, IIIExecutive Officer, Director
  • Garrett GrayExecutive Officer
  • Michael WeissDirector
  • Neil HerskowitzDirector
  • Scott BoilenDirector
  • Barry SalzmanDirector
  • Christian BechonDirector
  • Lindsay A. RosenwaldDirector
Placement agents
H.C. Wainwright & Co.
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$57.8MraisedSep 2016 · 559 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lindsay A. RosenwaldDirector
  • David J. HorinExecutive Officer
  • Michael S. WeissDirector
  • James F. Oliviero, IIIExecutive Officer
  • Neil HerskowitzDirector
  • Scott BoilenDirector
  • Barry SalzmanDirector
Offering amount
$62.5M
Amount sold
$57.8M
Sales commissions
$5.8M
Placement agents
National Securities Corporation
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Checkpoint Therapeutics raised?
Checkpoint Therapeutics has disclosed $57.8M raised across 1 of its 5 known rounds.
Where is Checkpoint Therapeutics headquartered?
Checkpoint Therapeutics is headquartered in Waltham, US.